Aligos Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Aligos Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2017 to Q3 2024.
  • Aligos Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 20.8M shares, a 93.5% decline year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 20.8M -299M -93.5% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 520M +200M +62.5% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 320M 0 0% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 12.8M -307M -96% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 320M 0 0% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 320M 0 0% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 320M 0 0% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 320M 0 0% Dec 31, 2022 10-K 2024-03-12
Q3 2022 320M 0 0% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 320M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 320M 0 0% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 320M 0 0% Dec 31, 2021 10-K 2023-03-09
Q3 2021 320M +42M +15.1% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 320M Jun 30, 2021 10-Q 2021-08-05
Q1 2021 320M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 320M +42M +15.1% Dec 31, 2020 10-K 2022-03-10
Q3 2020 278M Sep 30, 2020 10-Q 2020-11-25
Q4 2019 278M Dec 31, 2019 10-K 2021-03-23
Q3 2018 149M Aug 15, 2018 10-K 2021-03-23
Q2 2018 25M Jul 23, 2018 10-K 2021-03-23
Q4 2017 20M Feb 5, 2018 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.